# The Impact of Radiotherapy on Oligometastatic Cancer

> **NCT05933876** · — · RECRUITING · sponsor: **Institut Investigacio Sanitaria Pere Virgili** · enrollment: 2000 (estimated)

## Conditions studied

- Metastasis
- Metastatic Breast Cancer
- Metastatic Prostate Cancer
- Metastatic Colorectal Cancer
- Metastatic Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** To propose a diagnostic test to determine the viability of Stereotactic ABlative Radiotherapy (SABR).
- **DIAGNOSTIC_TEST:** To propose a diagnostic test to determine the effectiveness of SABR.
- **DIAGNOSTIC_TEST:** To propose a diagnostic test for Oligometastatic Cancer (OC).

## Key facts

- **NCT ID:** NCT05933876
- **Lead sponsor:** Institut Investigacio Sanitaria Pere Virgili
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2037-12-31
- **Final completion:** 2037-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2024-11-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05933876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05933876, "The Impact of Radiotherapy on Oligometastatic Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05933876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*